INSIGHTS ON CLINICAL TRIAL DESIGN
-
![From Data to Decisions]( "How AI Is Reshaping Clinical Development And Trial Execution")
How AI Is Reshaping Clinical Development And Trial ExecutionSee how AI, real-world data, and agentic technologies are helping clinical teams improve patient selection, streamline operations, and speed trial outcomes.
-
![clinical-trials-patients-GettyImages-1629549075]( "When Early CRO Wins Quietly Create Long-Term Study Risk")
When Early CRO Wins Quietly Create Long-Term Study RiskDiscover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.
-
![GettyImages-2103894533 office, team, coworkers, meeting]( "Accelerating Early Phase Oncology Study Development")
Accelerating Early Phase Oncology Study DevelopmentExplore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "Hybrid And Decentralized CNS Clinical Trials: Finding The Right Balance")
Hybrid And Decentralized CNS Clinical Trials: Finding The Right BalanceDecentralized and hybrid trial models are reshaping CNS research. Learn how to match virtual tools to your study design, endpoints, and patient population for better outcomes.
-
Flexible Supply Strategies For Complex Clinical Trials3/25/2026
Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.
-
Why Should Site Agility Be Your Next Competitive Advantage?1/26/2026
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.
-
Winning Enrollment In A Competitive CNS Trial Landscape7/29/2026
Many CNS trials today operate in a highly competitive environment. Enrollment success is shaped by the decisions teams make under these constraints.
-
The Realities Reshaping Phase I Trials For Sponsors9/15/2026
Phase I trials increasingly enroll patients and use expansion cohorts. Learn what this shift means for IRB review and sponsor planning.
-
Lessons From The Front Lines: Navigating The Operational Challenges Of Next-Generation ADC Trials9/22/2026
See how smarter protocol design and real-time safety monitoring can ease patient burden and keep next-gen ADC oncology trials on track.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1293772969 lab testing]( "How ClinicReady Delivers Foundations For Success")
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "Supporting Sites And Patients With People-First Solutions")
Discover how Scout supports patient retention with people-first solutions for reimbursement and travel at no cost to sites.
-
![GettyImages-1420647055 payments]( "Our Technology")
Built From The Ground Up
Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.
-
![Email Marketing]( "Lab Alerts: Target Relevant Patients For Clinical Trials")
Get near real-time notifications when a potential trial candidate presents in the clinic, which will help enable recruitment before the window of opportunity closes.
-
![New Anti-Cancer Drug Shows Promising Results With Low Toxicity]( "Bold Thinking Overcomes Oncology Clinical Development Challenges")
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
